Test Genetico Tumori
Citazioni per gli articoli di BRCA1/BRCA2
Al Bakir M, Gabra H. The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future. Br Med Bull. 2014 Dec;112(1):57-69.
Baretta Z, Mocellin S, Goldin E, Olopade OI, Huo D. Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine (Baltimore). 2016 Oct;95(40):e4975.
Castro E, Eeles R. The role of BRCA1 and BRCA2 in prostate cancer. Asian J Androl. 2012 May;14(3):409-14.
Chen S, Parmigiani G: Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007; 25: 1329–1333.
Cornejo-Moreno BA, Uribe-Escamilla D, Salamanca-Gómez F. Breast cancer genes: looking for BRACA’s lost brother. Isr Med Assoc J. 2014 Dec;16(12):787-92.
George SH, Shaw P. BRCA and Early Events in the Development of Serous Ovarian Cancer. Front Oncol. 2014 Jan 23;4:5.
Javle M, Golan T, Maitra A. Changing the course of pancreatic cancer–Focus on recent translational advances. Cancer Treat Rev. 2016 Mar;44:17-25.
Larsson, Borg, Hodgson, Sinilnikova, Loman, McDevitt, Müller-Reible, Kristoffersson. EMQN Best Practice Guidelines for Molecular Genetic Analysis in Hereditary Breast/Ovarian Cancer. EMQN workshop, 2007.
Lord CJ, Ashworth A. BRCAness revisited. Nat Rev Cancer. 2016 Feb;16(2):110-20.
Luo G, Lu Y, Jin K, Cheng H, Guo M, Liu Z, Long J, Liu C, Ni Q, Yu X. Pancreatic cancer: BRCA mutation and personalized treatment. Expert Rev Anticancer Ther. 2015;15(10):1223-31.
Mavaddat N, Peock S, Frost D et al: Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 2013; 105: 812–822.
Mavaddat N, Barrowdale D, Andrulis IL et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47.
Mocci E, Milne RL, Méndez-Villamil EY, Hopper JL et al. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):803-11.
Norquist BM, Harrell MI, Brady MF et al. Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016 Apr;2(4):482-90.
Paul A, Paul S. The breast cancer susceptibility genes (BRCA) in breast and ovarian cancers. Front Biosci (Landmark Ed). 2014 Jan 1;19:605-18.
Petrucelli, Daly and Feldman. BRCA1 and BRCA2 Hereditary Breast and Ovarian Cancer. 2013; PMID: PMID: 20301425
Sheikh A, Hussain SA, Ghori Q, Naeem N, Fazil A, Giri S, Sathian B, Mainali P, Al Tamimi DM. The spectrum of genetic mutations in breast cancer. Asian Pac J Cancer Prev. 2015;16(6):2177-85.
Skol AD, Sasaki MM, Onel K. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Res. 2016 Oct 3;18(1):99.
Suryavanshi M, Kumar D, Panigrahi MK, Chowdhary M, Mehta A. Detection of false positive mutations in BRCA gene by next generation sequencing. Fam Cancer. 2016 Nov 15. [Epub ahead of print]
Vergote I, Banerjee S, Gerdes AM, van Asperen C, Marth C, Vaz F, Ray-Coquard I, Stoppa-Lyonnet D, Gonzalez-Martin A, Sehouli J, Colombo N. Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients. Eur J Cancer. 2016 Nov 4;69:127-134.
Wallace. New challenges for BRCA testing: a view from the diagnostic laboratory. Eur J Hum Genet. 2016 Sep;24 Suppl 1:S10-8.
Wittersheim M, Büttner R, Markiefka B. Genotype/Phenotype correlations in patients with hereditary breast cancer. Breast Care (Basel). 2015 Feb;10(1):22-6.
Xu K, Yang S, Zhao Y. Prognostic significance of BRCA mutations in ovarian cancer: an updated systematic review with meta-analysis. Oncotarget. 2016 Sep 28.
Zaaijer LH, van Doorn HC, Mourits MJ, van Beurden M, de Hullu JA, Adank MA, van Lonkhuijzen LR, Vasen HF, Slangen BF, Gaarenstroom KN, Zweemer RP, Vencken PM, Seynaeve C, Kriege M. Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer. 2016 Nov 8;115(10):1174-1178.
Zhu Y, Wu J, Zhang C, Sun S, Zhang J, Liu W, Huang J, Zhang Z. BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis. Oncotarget. 2016 Sep 21. doi: 10.18632/oncotarget.12158. [Epub ahead of print]
Vedi i nostri pannelli relativi al cancro della mammella e dell’ovaio:
